Dr. John Inadomi
Colorectal Cancer Screening, Which Test Is Best?
80% by 2018 is a movement in which hundreds of organizations have committed to eliminating colorectal cancer as a major public health problem. However, there are multiple options available for colorectal cancer screening that vary in accuracy, interval, and harms.Read More
Dr. Sum Lee
The Changing Faces of Cholangitis
The term ‘cholangitis’ taken at face value means inflammation in the biliary system. This simple terminology is deceptive, however, as it encompasses a wide variety of diseases. This review highlights advances in research that point to novel insights into this diverse array of disorders.Read More
Dr. Scott Lee
Reinduction with Certolizumab Pegol in Patients with Crohn’s
Patients with Crohn’s disease, in whom anti-TNF therapy fails, have limited treatment options. Is there benefit to reintroducing the same therapy?Read More
Dr. Anita Afzali
Racial and Ethnic Minorities with IBD in the United States
IBD has predominantly affected whites, particularly Ashkenazi Jews. Over the last 2 decades, IBD has emerged in minorities. Differences in natural history and disease characteristics have been suggested. This systematic review summarizes these differences in studies from the U.S.Read More
Dr. Joo Ha Hwang
Screening and Surveillance for Gastric Cancer: Is It Needed?
The perception of gastric cancer in the US is that it is a relatively uncommon disease and that screening is not needed. However, most people do not realize that gastric cancer is more common than esophageal cancer in the US. Read More